W e determined that a remarkable group of autoantibodies, termed b2-glycoprotein-I (b2GPI)-dependent anti-cardiolipin (anti-CL), are elevated in a subgroup of individuals with generalized periodontitis. 1 Although these antibodies are found in only 1% to 5% of healthy adults, 2 we observed that nearly 20% of periodontitis patients displayed elevated levels of such antibodies. Elevated levels of anti-CL are found frequently in patients with systemic lupus erythematosus (SLE) and in the anti-phospholipid syndrome (APS), 3 with up to 80% of APS patients having elevated immunoglobulin G (IgG) or IgM anti-CL. 4 Notably, these antibodies are associated with clinical sequelae of thrombosis, stroke, myocardial infarction, early atherosclerosis, and adverse pregnancy outcomes, all of which have been suggested to be associated with periodontal infections. It was shown that a variety of microbial pathogens can induce such pathogenic cross-reactive autoantibodies in animals. [5] [6] [7] [8] [9] [10] [11] Studies of patients with SLE and APS indicated that antiphospholipid antibodies are associated with markers of endothelial cell activation and prothrombotic activity. 3, [12] [13] [14] [15] [16] [17] For example, pathogenic anti-CL in vitro promotes upregulation of endothelial cell intercellular adhesion molecule (ICAM-)1, vascular cell adhesion molecule (VCAM)-1, and E-selectin expression. Furthermore, sera from SLE patients with elevated levels of anti-CL also contain elevated concentrations of soluble (s) ICAM-1, sVCAM-1, and sE-selectin. It was proposed further that upregulation of E-selectin may mediate some of the prothrombotic pathological effects of anti-CL. 18 We hypothesized that anti-CL in a subset of periodontitis patients plays an important role in the observed systemic association of periodontitis with stroke, myocardial infarction, and adverse pregnancy outcomes. If this is correct, one would expect that periodontitis patients with elevated anti-CL also would display elevated levels of markers of endothelial cell activation. In this study, we assessed sICAM-1, sVCAM-1, and sE-selectin in periodontitis patients with and without elevated anti-CL and in healthy controls. The results indicated that there are strong associations between elevated anti-CL and markers of systemic vascular inflammation in aggressive periodontitis patients.
MATERIALS AND METHODS

Clinical Methods
This study was approved by the Office of Research Subjects Protection for the Conduct of Human Research of Virginia Commonwealth University. Subjects for this study were recruited through the Virginia Commonwealth University School of Dentistry Clinics between September 1976 and May 2004. The 280 patients selected for this study represented 90 periodontally healthy subjects and 190 periodontitis patients with elevated or normal serum levels of anti-CL. All subjects provided informed consent for the use of their serum samples. All subjects were determined to have no history of diabetes, coronary artery disease, or stroke. Data on smoking history and racial category were determined by self-report; 70 subjects failed to report smoking status. A complete periodontal evaluation, including assessments of probing depth, attachment loss (AL), plaque index, 19 gingival index, 20 bleeding upon probing, 21 and suppuration, 22 was performed on each participant. Measurements were performed at four sites per tooth (mesio-buccal, mid-buccal, disto-buccal, and mid-lingual). At the time of the examination, a blood sample was taken and processed for serum; it was stored at -70°C until utilized.
The subjects were categorized by diagnostic group as follows. Subjects who were periodontally healthy (NP) were those of any age with no evidence of AL or pockets >3 mm, i.e., had no detectable periodontitis. Chronic periodontitis (CP) subjects were >25 years of age with AL ‡2 mm in any extent or severity pattern on more than one tooth, consistent with plaque level and age and no indication of juvenile onset. Generalized aggressive periodontitis (GAgP) subjects were those with a history of disease onset up to age 35 years, with at least eight teeth affected ( ‡5 mm AL), at least three of which were not first molars and incisors.
Laboratory Methods
All antibodies and antigens were assessed by enzymelinked immunosorbent assay (ELISA). For determination of IgG and IgM anti-CL, we utilized ELISA kits. i ¶ For each anti-CL assay, an elevated test was defined as >15 units/ml according to the manufacturer. According to the manufacturer, levels of anti-CL in >95% of the normal healthy population are <11.7 U/ml; this result was reproduced in our laboratory for the reported population. Assays for sICAM-1, sVCAM-1, and sE-selectin also used ELISA kits. # ** † †
Statistical Analyses
For each marker, differences among the groups (periodontal diagnostic categories or elevated versus normal antibody status) were assessed by analysis of variance followed by Tukey's honestly significance difference (HSD) post hoc test. Multivariable analysis of covariance was used to adjust for periodontal diagnostic categories and demographic variables. Table 1 depicts the clinical and demographic characteristics of the three diagnostic groups. Univariate analyses indicated that significant differences in age, AL, probing depth, and number of teeth were present (P <0.05) and were characteristic of the clinical groups. The distribution of the diagnostic groups by race was different, with white subjects accounting for about half of the periodontitis groups and ;72% of the healthy subject group.
RESULTS
Subject Characteristics
Relationships Between Periodontal Diagnosis and Concentrations of sICAM-1, sVCAM-1, and E-Selectin Only E-selectin levels were significantly different between the diagnostic groups; sera from the NP subjects contained significantly lower concentrations of sE-selectin compared to CP patients (Table 2 ). In the subset of patients who were smokers, patients with periodontitis had elevated levels of sVCAM-1 compared to healthy control subjects.
Associations of Elevated Anti-CL With Cell Adhesion Molecules
Anti-CL was associated significantly with sVCAM-1 and sE-selectin levels (Table 3) . Subjects with elevated anti-CL had significantly higher serum concentrations of sVCAM-1 and sE-selectin than did subjects with normal levels of anti-CL. Because of literature indicating that smoking influences serum adhesion molecule concentrations and the problems that are inherent in statistically adjusting for the effects of smoking on periodontitis and vascular sequelae, we performed separate analyses on the 122 subjects who reported to never have smoked. No significant associations between periodontal diagnosis and vascular inflammatory marker levels were noted in this group of subjects (Table 2) . However, the associations between anti-CL antibody elevation and increased levels of sVCAM-1 and sE-selectin were still noted in the never-smokers, and it remained statistically significant (Table 3) . No significant dose relationships between IgG or IgM anti-CL and markers of vascular inflammation were noted. We further observed that associations between anti-CL and serum levels of cell adhesion molecules were not significant if only subjects who currently smoked were considered (Table 3) .
Following adjustments for demographic and clinic variables, serum levels of sVCAM-1 and sE-selectin remained associated significantly with anti-CL levels (Table 4) . Additionally, sICAM-1 was associated strongly with race; white subjects demonstrated higher adjusted serum levels (290.5 -15.5 mg/ml) than black subjects (220.4 -18.9 mg/ml; P = 0.0005). We also noted that sVCAM-1 was higher in white subjects (813.2 -35.8 mg/ml) than in black subjects (601.8 -43.6 mg/ml; P <0.0001) and that sE-selectin levels were higher in males (91.7 -7.1 mg/ml) than in females (76.2 -5.3 mg/ml; P = 0.02).
Next, we examined the relationships between anti-CL and cell adhesion molecule levels within the diagnostic groups. As shown in Table 5 , there was a strong relationship between elevated anti-CL and higher concentrations of sICAM-1, sVCAM-1, and sE-selectin in the GAgP group. Although only 13 of the 90 subjects with GAgP were never-smokers, and three of those 13 never-smokers had elevated anti-CL, these relationships still held in this small never-smoker subset and were statistically significant (for sVCAM-1, P = 0.01; for sE-selectin, P = 0.02). The associations of sVCAM-1 and sE-selectin levels with elevated anti-CL were still noted following statistical correction for age, race, gender, probing depth, AL, and number of teeth (Table 6 ). Further exploration of relationships of anti-CL with cell adhesion molecules in the CP group revealed that there were no significant relationships between any of the reported clinical indices (including mean probing depth, mean AL, mean number of teeth) and anti-CL (elevated or normal) or with concentrations of IgG anti-CL or IgM anti-CL. Finally, we examined associations of serum cell adhesion molecules with individual immunoglobulin isotypes IgG and IgM. For the NP and CP subject groups, no significant associations were found between antibody levels and serum cell adhesion molecule concentrations. However, for the GAgP group, following adjustment for demographic and periodontal variables there were significant associations between IgG anti-CL and sICAM-1 (P = 0.04), sVCAM-1 (P = 0.05), and sE-selectin (P = 0.001). IgM anti-CL was associated significantly with sVCAM-1 (P = 0.04).
DISCUSSION
The principal new finding in this study was that aggressive periodontitis patients with elevated anti-CL antibody concentrations were significantly more likely to have higher levels of sICAM-1, sVCAM-1, and sE-selectin. Even following statistical adjustment for demographic and periodontal variables, sVCAM-1 and sE-selectin levels remained associated significantly with anti-CL. Thus, the subset of aggressive periodontitis patients with elevated levels of anti-CL demonstrated an increase in measures of systemic vascular inflammation. Because ;20% of periodontitis patients seem to have elevated serum anti-CL levels, 1 the presence of such antibodies may be a marker for a subset of aggressive periodontitis patients with increased risk for cardiovascular and obstetrical sequelae.
AgP represents a frequently familial subform of periodontitis characterized by early age of onset (often in the late teens and early twenties) and rapidly progressive loss of periodontal attachment. 23 Data from our laboratory indicated that AgP patients demonstrated increased serum concentrations of C-reactive protein, 24 indicating that many of these patients are experiencing a systemic inflammatory response related to their periodontal infection. Although serum cell adhesion molecule concentrations are not elevated in AgP in general (Table 2 ), a subset of such patients with elevated anti-CL also have elevated levels of sVCAM-1 and sE-selectin (Tables  5 and 6 ). Although AgP patients have not been studied systematically with respect to systemic sequelae associated with periodontal infection, our data indicated that these patients may be especially susceptible to conditions associated with systemic inflammation.
The observation that a significant proportion of GAgP patients, as well as CP patients, have elevated anti-CL raises the question of the possible source of such antibodies. Anti-CL autoantibodies are found frequently in patients with SLE, and they are characteristic of APS. Recent studies strongly implicated bacterial and viral infections in the etiology of APS because of the induction of cross-reactive anti-CL autoantibodies by microbial pathogens. [5] [6] [7] [8] [9] [10] [11] Following production of a series of monoclonal antibodies reactive with b2GPI, Blank et al. 25 identified a hexapeptide (TLRVYK) sequence in b2GPI that is recognized by some anti-b2GPI monoclonal antibodies. A Basic Local Alignment Search Tool (BLAST) database search revealed that several common bacterial and viral pathogens contained peptide sequences with sequence homology to the b2GPI peptide. Furthermore, mice immunized with microbial pathogens, such as Haemophilus influenzae or Neisseria gonorrhea, that contained homologous sequences related to TLRVYK produced cross-reactive anti-b2GPI. Such antibodies could be isolated by affinity chromatography and induced APS-like symptoms, such as fetal involution, when infused passively into mice. Thus, bacterial infections could lead to the production of pathogenic anti-CL and be responsible for at least a subset of cases of APS. Our observation that patients with periodontitis seemed to have a relatively high prevalence of b2GPI-dependent anti-CL prompted us to search for peptide sequences homologous to TLRVYK in oral The observation that anti-CL is associated with elevated markers of vascular inflammation in aggressive, but not chronic, periodontitis might be explained by the severity and intensity of the exposure of GAgP patients to bacterial antigens and by host response factors that place them at risk for this form of periodontitis. Characteristic of patients with APS is the fact that their anti-CL titers are elevated persistently when tested ‡6 weeks apart. Given the more acute and severe nature of infection in AgP, it might be expected that long-term and persistent systemic exposure to cross-reactive antigens from the periodontal pocket might be more common in aggressive periodontitis than in CP. Furthermore, the underlying genetic factors conferring susceptibility to aggressive periodontitis may relate to the host response to bacterial antigens and have factors in common with susceptibility to APS.
Previous studies demonstrated that smoking influenced serum cell adhesion molecule concentrations and anti-CL levels. The results of studies of serum cell adhesion molecules have been variable. Most reports indicated that there were increased sICAM-1 levels in smokers, [26] [27] [28] which decreased with smoking cessation. 26 In contrast, Blann et al. 29 and Mizia-Stec et al. 30 reported no influence of smoking on sICAM-1 levels. Increases in sVCAM-1 levels in smokers have been reported, 29 whereas other investigators demonstrated no effect of smoking on sVCAM-1. 26, 30 Lain et al. 28 reported a decrease in sE-selectin levels in smokers, whereas Mizia-Stec et al. 30 reported no change. Fickl et al. 31 reported an increase in anti-CL levels in smokers. The preponderance of data indicated that smoking influenced serum cell adhesion molecule levels and underscores the necessity of demonstrating that concentrations of these inflammatory markers in periodontitis patients are independent of smoking. Our results in a substantial subset of never-smoking subjects demonstrated that associations of anti-CL with these markers was independent of smoking. Furthermore, analyses of these relationships in current smokers revealed that elevated levels of these markers (due to smoking) likely masked the effects of periodontitis on cell adhesion molecule concentrations.
As in prior studies, we were unable to demonstrate in a never-smoking subset of subjects that any of the three markers of vascular inflammation differed between patients with periodontitis and subjects who were periodontally healthy. This result is consistent with that of Glurich et al., 32 who found no differences in sICAM-1 and sVCAM-1 between periodontal diagnostic groups. Results of multivariate analyses in this patient population further indicated that there are relationships between serum adhesion molecule levels and race and/or gender. The results with respect to racial differences are consistent with those of Miller et al., 33 who noted that individuals of African origin residing in England had lower levels of sICAM-1, sVCAM-1, and sP-selectin than white subjects.
Antiphospholipids are associated with the elevation of factors associated with dysregulation of endothelial cell function, damage to endothelial cells, and accelerated thrombosis, including sICAM, sVCAM-1, The interaction of anti-CL with endothelial monolayers seems to be dependent upon b2GPI, implying an indirect interaction between antibody and endothelial cell surface. Our observation that elevation of anti-CL was associated with increased levels of sVCAM-1, but not sICAM-1, in periodontitis is consistent with the results of Kaplanski et al. 13 for patients with APS. Other studies of APS and SLE demonstrated elevation of sICAM-1 and sVCAM-1. 14, 15 Nearly all studies indicated that levels of these cell adhesion molecules rarely are elevated in concert. Similarly, studies of the effects of smoking on serum adhesion molecule levels demonstrated that concentrations of sICAM-1, sVCAM-1, and sE-selectin in serum are regulated independently. Thus, it seems from the present study and many others that the activation of endothelial cells in association with anti-CL or other stimuli does not necessarily result in expression of elevated levels of all classes of cell adhesion molecules in serum. Neither the interactions that lead to increased expression of these molecules nor the factors that regulate their serum concentrations are understood completely. Our data support the hypothesis that the strong associations between anti-CL and sVCAM-1 and sEselectin indicate that increases in systemic vascular inflammation in periodontitis patients may occur as a result of an immune response to periodontal disease pathogens resulting in the formation of cross-reactive autoantiphospholipid antibodies.
